Humana Inc. (NYSE:HUM) – Leerink Swann boosted their Q3 2016 earnings per share (EPS) estimates for Humana in a report released on Monday. Leerink Swann analyst A. Gupte now forecasts that the firm will earn $3.15 per share for the quarter, up from their previous forecast of $2.85. Leerink Swann currently has a “Outperform” rating on the stock. Leerink Swann also issued estimates for Humana’s Q4 2016 earnings at $2.20 EPS, FY2016 earnings at $9.50 EPS, FY2018 earnings at $12.50 EPS and FY2019 earnings at $14.00 EPS.
Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, August 3rd. The insurance provider reported $2.30 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.23 by $0.07. The company earned $14 billion during the quarter, compared to the consensus estimate of $13.59 billion. Humana had a net margin of 1.76% and a return on equity of 11.11%. Humana’s revenue for the quarter was up 2.0% on a year-over-year basis. During the same period last year, the firm earned $1.67 EPS.
Other research analysts have also recently issued reports about the stock. Zacks Investment Research raised shares of Humana from a “hold” rating to a “buy” rating and set a $198.00 target price for the company in a report on Tuesday, October 4th. Credit Suisse Group AG reaffirmed a “hold” rating on shares of Humana in a report on Tuesday, June 28th. Cantor Fitzgerald reaffirmed a “buy” rating on shares of Humana in a report on Saturday, July 9th. Royal Bank Of Canada lifted their target price on shares of Humana from $220.00 to $224.00 and gave the stock an “outperform” rating in a report on Friday, July 22nd. Finally, Wolfe Research raised shares of Humana to an “outperform” rating and set a $192.00 target price for the company in a report on Thursday, July 21st. Seven research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. Humana has a consensus rating of “Buy” and an average target price of $200.50.
Humana (NYSE:HUM) opened at 173.27 on Tuesday. The company has a market capitalization of $25.83 billion, a P/E ratio of 26.62 and a beta of 0.90. Humana has a 12-month low of $150.00 and a 12-month high of $191.65. The company has a 50-day moving average of $175.62 and a 200 day moving average of $175.43.
The firm also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Investors of record on Thursday, October 13th will be issued a $0.29 dividend. This represents a $1.16 dividend on an annualized basis and a yield of 0.67%. The ex-dividend date of this dividend is Tuesday, October 11th. Humana’s dividend payout ratio (DPR) is 18.18%.
A number of institutional investors have recently made changes to their positions in the stock. Point72 Asia Hong Kong Ltd purchased a new stake in Humana during the second quarter valued at $126,000. Daiwa SB Investments Ltd. increased its stake in Humana by 1.4% in the third quarter. Daiwa SB Investments Ltd. now owns 730 shares of the insurance provider’s stock valued at $129,000 after buying an additional 10 shares during the last quarter. Bessemer Group Inc. increased its stake in Humana by 392.6% in the first quarter. Bessemer Group Inc. now owns 1,000 shares of the insurance provider’s stock valued at $183,000 after buying an additional 797 shares during the last quarter. Fulton Bank N.A. purchased a new stake in Humana during the third quarter valued at $229,000. Finally, BB&T Securities LLC increased its stake in Humana by 13.6% in the second quarter. BB&T Securities LLC now owns 1,374 shares of the insurance provider’s stock valued at $247,000 after buying an additional 165 shares during the last quarter. 93.27% of the stock is owned by hedge funds and other institutional investors.
Humana Company Profile
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.